Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Dihydroergotoxine MeSH Descriptor Data 2025


MeSH Heading
Dihydroergotoxine
Tree Number(s)
D03.132.327.412.250
D03.633.400.562.400
Unique ID
D004088
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004088
Scope Note
A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES.
Entry Term(s)
Co-Dergocrine
Dihydroergotoxin
Ergot Alkaloids, Hydrogenated
Pharm Action
Adrenergic alpha-Antagonists
Dopamine Agonists
Registry Numbers
11032-41-0
0
CAS Type 1 Name
Ergotoxine, dihydro-
Previous Indexing
Ergot Mesylates (1973-1974)
See Also
Dihydroergocornine
Dihydroergocristine
Dihydroergocryptine
Public MeSH Note
1977; see ERGOT ALKALOIDS HYDROGENATED 1975-1976; for ERGOT ALKALOIDS, HYDROGENATED see ERGOLOID MESYLATES 1992-2001
History Note
1977(1975); for ERGOT ALKALOIDS, HYDROGENATED use ERGOLOID MESYLATES 1992-2001
Date Established
1977/01/01
Date of Entry
1974/11/27
Revision Date
2016/05/31
Dihydroergotoxine Preferred
Ergot Alkaloids, Hydrogenated Broader
page delivered in 0.149s